Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (XVIPF)
:XVIPF
Holding XVIPF?
Track your performance easily
XVIPF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$24.56 - $52.48
Previous CloseN/A
Volume100.00
Average Volume (3M)48.00
Market Cap
$1.23B
Enterprise Value$15.77B
Total Cash (Recent Filing)$23.37M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)62.8
Beta1.01
Next Earnings
Jan 28, 2025EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.61
Shares Outstanding31,499,470
10 Day Avg. Volume115
30 Day Avg. Volume48
Standard Deviation0.17
R-Squared0.00236
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)18.95
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap12.85
Enterprise Value/Revenue34.03
Enterprise Value/Gross Profit53.09
Enterprise Value/Ebitda534.41
Forecast
1Y Price Target
$44.67Price Target Upside11.70% Upside
Rating ConsensusHold
Number of Analyst Covering1
Xvivo Perfusion AB News
PremiumCompany Announcements
XVIVO Perfusion AB Reports Strong 2024 Growth
PremiumPre-Earnings
Is XVIPF a Buy, Before Earnings?
PremiumPre-Earnings
Is XVIPF a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.10% Mutual Funds
― Other Institutional Investors
93.86% Public Companies and
Individual Investors
XVIPF FAQ
What was Xvivo Perfusion AB’s price range in the past 12 months?
Xvivo Perfusion AB lowest stock price was $24.56 and its highest was $52.48 in the past 12 months.
What is Xvivo Perfusion AB’s market cap?
Xvivo Perfusion AB’s market cap is $1.23B.
When is Xvivo Perfusion AB’s upcoming earnings report date?
Xvivo Perfusion AB’s upcoming earnings report date is Jan 28, 2025 which is 3 days ago.
How were Xvivo Perfusion AB’s earnings last quarter?
Xvivo Perfusion AB released its earnings results on Jan 28, 2025. The company reported $0.109 earnings per share for the quarter, missing the consensus estimate of $0.126 by -$0.017.
Is Xvivo Perfusion AB overvalued?
According to Wall Street analysts Xvivo Perfusion AB’s price is currently Undervalued.
Does Xvivo Perfusion AB pay dividends?
Xvivo Perfusion AB does not currently pay dividends.
What is Xvivo Perfusion AB’s EPS estimate?
Xvivo Perfusion AB’s EPS estimate is 0.13.
How many shares outstanding does Xvivo Perfusion AB have?
Xvivo Perfusion AB has 31,499,470 shares outstanding.
What happened to Xvivo Perfusion AB’s price movement after its last earnings report?
Xvivo Perfusion AB reported an EPS of $0.109 in its last earnings report, missing expectations of $0.126. Following the earnings report the stock price went up 5.873%.
Which hedge fund is a major shareholder of Xvivo Perfusion AB?
Currently, no hedge funds are holding shares in XVIPF
---
Company Description
Xvivo Perfusion AB
Xvivo Perfusion AB is a medical technology company which develops and markets innovative system solutions for the preservation and evaluation of donated organs outside the body awaiting transplantation. The company supply transplantation clinics worldwide with advanced technological products for the preservation and evaluation of lungs.
---
XVIPF Company Deck
---
XVIPF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a strong quarter with significant growth in the Thoracic and Liver segments, complemented by successful heart trials and strategic acquisitions. However, challenges in the Abdominal and Services segments, along with hurdles in launching Kidney Assist Transport in the U.S., balanced the overall sentiment.Read More>---
Technical Analysis
---